Overview

For procurement teams, entrectinib's value lies in its tissue-agnostic NTRK and ROS1 label and the supply discipline required to keep a 200 mg capsule stable across long international routes. Reliable sourcing means verifying GMP certification, batch-release documents, and a cold-chain partner able to hold 2–8 °C from origin to clinic. The 90-capsule pack supports a continuous outpatient regimen, so uninterrupted delivery matters more than marginal unit-price differences. Qualified distributors should treat documentation integrity as the primary purchase criterion.

How It Works

Entrectinib is a orally delivered inhibitor of the TRK A/B/C, ROS1, and ALK kinase domains, which are constitutively active in NTRK gene fusions or ROS1 rearrangements. By occupying the ATP-binding site it stops downstream MAPK and PI3K signaling that would otherwise drive tumor growth. A practical advantage for sourcing is its brain penetration, so the same capsule supplies both systemic and CNS disease sites, reducing the need for separate formulations. From a logistics view the molecule is stable enough for standard refrigerated transit when the original blister is unopened.

Indications

Entrectinib is approved for solid tumors harboring an NTRK gene fusion, regardless of tissue origin, and for ROS1-positive non-small cell lung cancer. Companion diagnostics confirming the relevant genomic alteration are mandatory before supply. Because the label is tumor-agnostic, demand can come from multiple specialty departments, so forecasting should track genomic-test volumes rather than a single indication. Treatment continues while clinical benefit is observed.

Dosage & Administration

Adult dosing is calculated by body-surface area, commonly 600 mg taken orally once daily, assembled from the 200 mg capsules. Pediatric and reduced-dose schedules follow labeled guidance. Capsules are taken with or without food, and doses are omitted rather than doubled after a missed administration. Procurement plans should align pack sizes with the prescribed daily count to avoid partial-pack waste.

Storage & Sourcing

Maintain 2–8 °C refrigeration in the original container, protected from light and moisture; do not freeze. The 90-capsule pack should ship inside a validated insulated carton with temperature logger. On receipt, verify the cold-chain record, batch certificate, and expiry. Stocks should rotate by earliest expiry, and any pack exposed to ambient heat beyond labeled limits should be quarantined and returned per the supplier agreement.

FAQ

Q: What cold-chain conditions are required when importing entrectinib capsules?

A: Ship and store at 2–8 °C in the original blister inside an insulated, logged carton. Maintain the chain unbroken from manufacturer to clinic and review the temperature record on receipt before stocking.

Q: What quality documents should accompany a B2B entrectinib shipment?

A: Expect a certificate of analysis, GMP attestation, batch release, and the importing territory's authorization reference. Reputable suppliers provide these with every batch, not on request only.

Q: What is a typical minimum order quantity for Rozlytrek 200 mg?

A: MOQ varies by supplier and territory, but a 90-capsule pack is the usual commercial unit; tender buyers often contract several packs to cover a treatment quarter without gaps.

Q: How should buyers verify entrectinib authenticity on arrival?

A: Cross-check the batch number and serial on the carton against the supplied COA, confirm intact tamper seals, and validate the manufacturer identifier before adding the stock to inventory.